LeMaitre Vascular, Inc.LMATNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +13.98% | +11.95% | +15.01% | +11.36% | +15.68% |
| Gross Profit Growth | +16.01% | +12.97% | +16.91% | +23.61% | +19.69% |
| EBITDA Growth | +35.03% | +19.13% | +23.07% | +70.05% | +20.08% |
| Operating Income Growth | +25.95% | +6.33% | +12.25% | +54.49% | +46.51% |
| Net Income Growth | +32.12% | +11.37% | +16.51% | +55.84% | +39.32% |
| EPS Growth | +31.58% | +13.95% | +15.09% | +54.00% | +38.00% |
| EPS Diluted Growth | +28.95% | +11.63% | +15.38% | +53.06% | +38.78% |
| Weighted Average Shares Growth | +1.02% | +0.50% | +0.69% | +0.82% | +0.90% |
| Weighted Average Shares Diluted Growth | +1.97% | +0.77% | +0.73% | +6.81% | +0.29% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +41.28% | +0.00% | +110.82% | +101.91% | +52.53% |
| Free Cash Flow Growth | +38.78% | +0.00% | +144.60% | +110.58% | +62.73% |
| Receivables Growth | +19.94% | +0.00% | +18.54% | +0.46% | +11.80% |
| Inventory Growth | +6.90% | +0.00% | +1.41% | +24.01% | +25.88% |
| Asset Growth | +59.13% | +0.00% | +59.08% | +58.63% | +11.58% |
| Book Value per Share Growth | +12.08% | +0.00% | +12.72% | +13.52% | +15.63% |
| Debt Growth | +872.43% | +0.00% | +909.77% | +912.94% | -0.05% |
| R&D Expense Growth | -16.85% | +0.07% | -17.34% | -18.76% | -2.35% |
| SG&A Expenses Growth | +18.23% | +19.32% | +27.71% | +11.28% | +7.72% |